HYPR vs RDNT
HYPR: Hyperfine makes AI-powered portable ultra-low-field MRI systems designed to bring affordable brain imaging to hospitals and clinics anywhere, without specialized facilities or technicians. RDNT: Leading operator of multi-modality diagnostic imaging centers across the US, with integrated AI-powered radiology software and digital health solutions.
Side-by-side fundamentals
| Metric | HYPR | RDNT | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $0.98 | $59.22 | |
| Market cap as of 2026-07-23 | $100M | $4.8B | |
| Net margin as of 2026-07-23 | -226.9% | -0.7% | RDNT higher |
| Gross margin as of 2026-07-23 | +51.2% | +24.1% | HYPR higher |
| Operating margin as of 2026-07-23 | -226.6% | +2.9% | RDNT higher |
| ROE as of 2026-07-23 | -101.3% | -1.4% | RDNT higher |
| ROA as of 2026-07-23 | -68.8% | -0.4% | RDNT higher |
| Debt / equity as of 2026-07-23 | 0.38 | 1.01 | HYPR lower |
| Revenue growth (YoY) as of 2026-07-23 | +30.7% | +14.7% | HYPR higher |
| Revenue CAGR (3y) SEC XBRL | +25.8% | +12.6% | HYPR higher |
| Beta as of 2026-07-23 | 1.43 | 1.41 | |
| 1-year return as of 2026-07-22 close | +2.3% | +3.6% | RDNT higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.